Najla Long guides hospitals, health systems and other healthcare providers in antitrust and competition issues. She has particular experience advising public and private companies in merger and acquisition issues involving the US Department of Justice and Federal Trade Commission.
Najla’s practice includes all aspects of antitrust compliance, including various documents and filings for federal antitrust authorities. These include HSR filings, voluntary submissions, Second Request responses and submissions required by consent decrees.
She also guides healthcare clients in resolving antitrust disputes, including through litigation involving competition-related issues. In addition, Najla guides clients in creating and maintaining effective antitrust compliance programs.
While her current practice focuses on the healthcare industry, Najla has antitrust experience in a wide range of industry sectors, including agriculture, consumer products, media, private equity, life sciences and retail.
- American Bar Association
- Attorney Program Volunteer, New York Family Court
- Alumni Interviewer, Harvard Schools Committee of New York
- Alumni Liaison, Harvard Outreach Committee
Any result the lawyer or law firm may have achieved on behalf of clients in other matters does not necessarily indicate similar results can be obtained for other clients.
- Represented a NASDAQ-listed telecommunications technology company before FTC for potential competition issues related to $1.1 billion sale to a competitor.
- Advised and managed multinational beverage company's successful compliance with monthly monitoring and reporting requirements over a four-year period pursuant to a federal consent decree.
- Developed an advertised pricing policy for national consumer retailer with $1.8 billion in yearly revenues.
- Assisted in representation of international chemical and agricultural conglomerate during a federal antitrust investigation of $130 billion merger-of-equals.
- Assisted in global antitrust representation of Fortune 15 electronic and energy conglomerate before the European Commission in connection with $10 billion acquisition of a top competitor.